Clinical Trials Logo

Clinical Trial Summary

This is an open-label study to evaluate the safety, reactogenicity, and immunogenicity of mRNA-1273 Severe Acute Respiratory Syndrome coronavirus (SARS-CoV-2) vaccine in adults with a kidney or liver transplant and in healthy adult participants. The primary goal of the study is to evaluate the safety of mRNA-1273 and the serum antibody (Ab) responses obtained 28 days after the second dose of mRNA-1273.

Clinical Trial Description


Study Design

Related Conditions & MeSH terms

NCT number NCT04860297
Study type Interventional
Source ModernaTX, Inc.
Contact Moderna Clinical Trials
Phone 877-913-3286
Email [email protected]
Status Recruiting
Phase Phase 3
Start date April 16, 2021
Completion date August 26, 2022

See also
  Status Clinical Trial Phase
Recruiting NCT04512079 - FREEDOM COVID-19 Anticoagulation Strategy Phase 4
Active, not recruiting NCT04527471 - Study of Ensifentrine or Placebo Delivered Via pMDI in Hospitalized Patients With COVID-19 Phase 2
Not yet recruiting NCT04332666 - Angiotensin-(1,7) Treatment in COVID-19: the ATCO Trial Phase 2/Phase 3
Enrolling by invitation NCT04579549 - Repeat Testing for SARS-CoV-2 N/A
Active, not recruiting NCT04515147 - A Dose-Confirmation Study to Evaluate the Safety, Reactogenicity and Immunogenicity of Vaccine CVnCoV in Healthy Adults for COVID-19 Phase 2
Recruiting NCT04613310 - PCR and Rapid Diagnostic Test on Saliva and Nasopharyngeal Swabs for the Detection of SARS-CoV-2 (COVID-19) N/A
Recruiting NCT04747574 - Evaluation of the Safety of CD24-Exosomes in Patients With COVID-19 Infection Phase 1
Withdrawn NCT04388709 - Interferon Lambda Therapy for COVID-19 Phase 2
Not yet recruiting NCT04526769 - Detecting SARS-CoV-2 in Tears
Active, not recruiting NCT04620798 - Longitudinal COVID-19 Antibody Testing in Indiana University Undergraduate Students N/A
Enrolling by invitation NCT04561102 - Evaluation of the COVIDSeq Test in Nasal Swab and Saliva From a COVID-19 Asymptomatic Population
Completed NCT04690413 - NOWDx Test for the Detection of Antibodies to COVID-19 N/A
Not yet recruiting NCT04526821 - Lactoferrin for Prevention of COVID-19 in Health Care Workers Phase 2
Active, not recruiting NCT04546581 - Inpatient Treatment With Anti-Coronavirus Immunoglobulin (ITAC) Phase 3
Active, not recruiting NCT04530435 - PEP Flute-selfcare in COVID-19 N/A
Recruiting NCT04472611 - Colchicine/Statins for the Prevention of COVID-19 Complications (COLSTAT) Trial Phase 3
Recruiting NCT04565249 - Evaluation of the Safety, Tolerability, and Pharmacokinetics of PLN-74809 in Participants With Acute Respiratory Distress Syndrome (ARDS) Associated With at Least Severe COVID-19 Phase 2
Recruiting NCT04672343 - Prognostic Impact of the Nutritional Status of Individuals Aged 70 Years and Older With SARS-CoV-2
Recruiting NCT04448119 - Control of COVID-19 Outbreaks in Long Term Care Phase 2
Not yet recruiting NCT04335032 - EPA-FFA to Treat Hospitalised Patients With COVID-19 (SARS-CoV-2) Phase 3